Clinical predictive factors of the efficacy of immune checkpoint inhibitors and kinase inhibitors in advanced hepatocellular cancer
PLR and TC were potential clinical predictive factors for survival outcomes in patients with advanced HCC who received ICI/kinase inhibitor combination therapy. It is important to know the clinical characteristics of patients prior to treatment initiation to optimize outcomes.
Authors
- Yunyun Lu (ORCID: https://orcid.org/0009-0009-2095-389X)
- Yi Lu (ORCID: https://orcid.org/0000-0002-1599-8593)
Institutions
- Ningbo Medical Center Lihuili Hospital (CN)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1007/s12094-024-03644-9
- Citations
- 8
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.96